Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in LDL receptor-deficient mice.
about
Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic miceLarge animal models of cardiovascular diseaseInsulin resistance, hyperglycemia, and atherosclerosisPPARalpha deficiency reduces insulin resistance and atherosclerosis in apoE-null miceNaturally occurring and experimental diabetes in cynomolgus monkeys: a comparison of carbohydrate and lipid metabolism and islet pathology.Genetic modifiers of atherosclerosis in miceIncreased inflammation in atherosclerotic lesions of diabetic Akita-LDLr⁻/⁻ mice compared to nondiabetic LDLr⁻/⁻ miceAnimal models of cardiovascular diseasesApolipoprotein E4 exaggerates diabetic dyslipidemia and atherosclerosis in mice lacking the LDL receptor.Left ventricular diastolic dysfunction in nonhuman primate model of dysmetabolism and diabetesUncomplicating the Macrovascular Complications of Diabetes: The 2014 Edwin Bierman Award LectureMouse betaine-homocysteine S-methyltransferase deficiency reduces body fat via increasing energy expenditure and impairing lipid synthesis and enhancing glucose oxidation in white adipose tissueDiabetic vascular disease and the potential role of macrophage glucose metabolismDiabetes mellitus-associated atherosclerosis: mechanisms involved and potential for pharmacological invention.Tuning three-dimensional collagen matrix stiffness independently of collagen concentration modulates endothelial cell behaviorBerberine ameliorates cold and mechanical allodynia in a rat model of diabetic neuropathyMinimization of the Risk of Diabetic Microangiopathy in Rats by Nigella sativa.Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical ConsiderationsDoes Elevated Glucose Promote Atherosclerosis? Pros and Cons.Progression and disruption of advanced atherosclerotic plaques in murine models.Diabetes and atherosclerosis: is there a role for hyperglycemia?Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions.Diabetes and arterial extracellular matrix changes in a porcine model of atherosclerosis.2013 Russell Ross memorial lecture in vascular biology: cellular and molecular mechanisms of diabetes mellitus-accelerated atherosclerosis.Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis.Dichotomous mechanisms of aortic stiffening in high-fat diet fed young and old B6D2F1 miceIncreased CD36 protein as a response to defective insulin signaling in macrophagesWhy does diabetes increase atherosclerosis? I don't know!Improvement in myocardial function by Terminalia arjuna in streptozotocin-induced diabetic rats: possible mechanisms.Effects of diabetes and CETP expression on diet-induced atherosclerosis in LDL receptor-deficient mice.Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient mice.Expression of the human beta3 integrin subunit in mouse smooth muscle cells enhances IGF-I-stimulated signaling and proliferation.Diabetes with poor glycaemic control does not promote atherosclerosis in genetically modified hypercholesterolaemic minipigs.Hyperglycemia does not affect tissue repair responses in shear stress-induced atherosclerotic plaques in ApoE-/- mice.
P2860
Q24530027-5D4EF6F1-87B8-49EA-BA7E-EB967A68F810Q26766350-8468FA3A-E5D5-4237-8507-3A3C5A677C5CQ27011696-68E8FCCA-3004-4C19-90DF-53E3DEB80A10Q28362804-5727A874-57E3-4D8E-BAFF-028E23C6A88AQ32052554-77FB7EDC-D407-45D9-944D-85C1AB4DC3D3Q34080318-E7DF2A06-E944-4DA9-9585-C3D991DC226FQ34513915-C684C2C9-B0A4-420C-BF69-A708EA051067Q34591282-2C1A75DC-C2F0-44E6-AA10-B37CE773DD9DQ35179999-78017C31-9328-4B70-81B2-3F20375C030DQ35827889-9769B685-E58A-42A8-A9E5-7E80470AC912Q35881759-730278EB-3C2C-416A-939B-24B0D3E58E00Q35956425-0223EA4E-1D7E-4867-ABB7-66A0AE4A0215Q36199128-8C0BCAAE-7397-4767-95D0-97D0C80FD682Q36401585-7EDAF33F-800F-410C-A4E0-2ED3248EC591Q36428268-B3A7BB70-7664-4863-8F87-99C5DE356DC7Q36933488-8D225950-FA9D-497A-A0D4-5BC63440FC15Q36942584-36963912-5BF4-4D9F-AA61-A27832920F07Q37011769-4CE4665C-D2AE-40FE-8139-97D2C32840F8Q37083092-2EAF0B09-362A-4A33-BF2A-32DC41DE4045Q37108304-24FA68B8-ECC3-47EF-AC93-B93D498AC195Q37333371-35200787-EECC-416A-A559-80F0D71D461CQ37486465-F91B2F6B-1A9D-42E7-BDD7-B453DC6C2CE6Q37643127-FDF7E51D-A3AD-43E0-956F-941669F46811Q37666671-F74A68C4-886E-4BDD-A232-08BC27C3F3F2Q37711215-D23F7A0A-47A9-429B-A043-2D214A017BB5Q37727913-BB27B49C-CF30-45FD-9EFE-BAD7576BBD52Q38344254-D2E36754-CFA6-4F25-AE8B-3DC97AE2AD25Q39951404-C0A1CB83-8961-45D4-BD9A-390BCF9EB5A3Q44702438-F33269C6-E863-4545-8D2C-BBA0214289C4Q45241682-6E374CA4-698A-4CFF-8044-1FCD63C5BAFCQ46141600-AF623316-A72A-456E-BB66-C533F62DE540Q50963014-811E83EA-B40B-4EFB-B5C1-C0D60FE89367Q53486855-4B17BAAD-690D-41DF-8BE2-93384D435DF6Q55355643-1ED01020-B88E-4847-B76D-B03DEE67BE75
P2860
Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in LDL receptor-deficient mice.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Effect of streptozotocin-induc ...... n LDL receptor-deficient mice.
@en
Effect of streptozotocin-induc ...... n LDL receptor-deficient mice.
@nl
type
label
Effect of streptozotocin-induc ...... n LDL receptor-deficient mice.
@en
Effect of streptozotocin-induc ...... n LDL receptor-deficient mice.
@nl
prefLabel
Effect of streptozotocin-induc ...... n LDL receptor-deficient mice.
@en
Effect of streptozotocin-induc ...... n LDL receptor-deficient mice.
@nl
P2093
P1476
Effect of streptozotocin-induc ...... n LDL receptor-deficient mice.
@en
P2093
P304
P356
10.1161/01.ATV.17.10.2250
P407
P577
1997-10-01T00:00:00Z